April 19, 2024 10:45 AM EDT

Histogen files for bankruptcy; Barinthus Bio shares Ph1b/2 data for HPV treatment

ENDPOINTS

Plus, news about TScan Therapeutics:

Histogen files for Chapter 11 bankruptcy: The biotech, which stopped work in September,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

view job offer post your job now

TRENDING NOW

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

Revolution’s KRAS drugs appear competitive in several lung cancer settings

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

Corvus' early-phase atopic dermatitis data prompt stock rally

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges